CELLDEX THERAPEUTICS INC (CLDX) 46.09 +1.11 (+2.47%)
46.09 +1.11 (+2.47%)
US15117B2025 - Common Stock - After market: 46.09 0 (0%)
Buy % Consensus
Analysts have set a mean price target of 65.62. This target is 42.37% above the current price.
CLDX was analyzed by 12 analysts. The buy percentage consensus is at 87. So analysts seem to be very confident about CLDX.
In the previous month the buy percentage consensus was at a similar level.
CLDX was analyzed by 12 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target
Up and Down Grades
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2022-11-11 | Guggenheim | Maintains | Buy |
| 2022-08-09 | SVB Leerink | Maintains | Outperform |
| 2022-07-01 | HC Wainwright & Co. | Maintains | Buy |
| 2021-09-17 | Jefferies | Initiate | Buy |
| 2021-09-13 | HC Wainwright & Co. | Maintains | Buy |
| 2021-09-10 | SVB Leerink | Initiate | Outperform |
| 2021-08-06 | HC Wainwright & Co. | Maintains | Buy |
| 2021-07-22 | Guggenheim | Initiate | Buy |
| 2021-07-12 | HC Wainwright & Co. | Maintains | Buy |
| 2021-02-23 | HC Wainwright & Co. | Maintains | Buy |
Analyst Ratings Stock Screener Links
Best Analyst Rating Competitors Stock Screener
Find the competitors with the best analyst ratings on the USA